163 related articles for article (PubMed ID: 26907470)
1. Supramolecular assemblies of histidinylated β-cyclodextrin for enhanced oligopeptide delivery into osteoclast precursors.
Liu W; Zhang X; Wang R; Xu H; Chi B
J Biomater Sci Polym Ed; 2016; 27(6):490-504. PubMed ID: 26907470
[TBL] [Abstract][Full Text] [Related]
2. Oligopeptide delivery carrier for osteoclast precursors.
Chi B; Park SJ; Park MH; Lee SY; Jeong B
Bioconjug Chem; 2010 Aug; 21(8):1473-8. PubMed ID: 20715852
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional Poly(methyl vinyl ether-co-maleic anhydride)-graft-hydroxypropyl-β-cyclodextrin Amphiphilic Copolymer as an Oral High-Performance Delivery Carrier of Tacrolimus.
Zhang D; Pan X; Wang S; Zhai Y; Guan J; Fu Q; Hao X; Qi W; Wang Y; Lian H; Liu X; Wang Y; Sun Y; He Z; Sun J
Mol Pharm; 2015 Jul; 12(7):2337-51. PubMed ID: 26024817
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of osteoclast differentiation by gold nanoparticles functionalized with cyclodextrin curcumin complexes.
Heo DN; Ko WK; Moon HJ; Kim HJ; Lee SJ; Lee JB; Bae MS; Yi JK; Hwang YS; Bang JB; Kim EC; Do SH; Kwon IK
ACS Nano; 2014 Dec; 8(12):12049-62. PubMed ID: 25420230
[TBL] [Abstract][Full Text] [Related]
5. Development of a new delivery system consisting in 'drug-in cyclodextrin-in PLGA nanoparticles'.
Mura P; Maestrelli F; Cecchi M; Bragagni M; Almeida A
J Microencapsul; 2010; 27(6):479-86. PubMed ID: 20113170
[TBL] [Abstract][Full Text] [Related]
6. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
[TBL] [Abstract][Full Text] [Related]
7. The intracellular effects of non-ionic amphiphilic cyclodextrin nanoparticles in the delivery of anticancer drugs.
Quaglia F; Ostacolo L; Mazzaglia A; Villari V; Zaccaria D; Sciortino MT
Biomaterials; 2009 Jan; 30(3):374-82. PubMed ID: 18930312
[TBL] [Abstract][Full Text] [Related]
8. A novel prototype of albumin nanoparticles fabricated by supramolecular cyclodextrin-adamantane association.
Lee S; Lee C; Kim B; Thao LQ; Lee ES; Kim JO; Oh KT; Choi HG; Youn YS
Colloids Surf B Biointerfaces; 2016 Nov; 147():281-290. PubMed ID: 27522557
[TBL] [Abstract][Full Text] [Related]
9. Skin transport of PEGylated poly(ε-caprolactone) nanoparticles assisted by (2-hydroxypropyl)-β-cyclodextrin.
Conte C; Costabile G; d'Angelo I; Pannico M; Musto P; Grassia G; Ialenti A; Tirino P; Miro A; Ungaro F; Quaglia F
J Colloid Interface Sci; 2015 Sep; 454():112-20. PubMed ID: 26004575
[TBL] [Abstract][Full Text] [Related]
10. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
12. Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery.
Chen J; Li S; Shen Q
Eur J Pharm Sci; 2012 Sep; 47(2):430-43. PubMed ID: 22796217
[TBL] [Abstract][Full Text] [Related]
13. PLGA nanoparticles loaded with the antileishmanial saponin β-aescin: factor influence study and in vitro efficacy evaluation.
Van de Ven H; Vermeersch M; Matheeussen A; Vandervoort J; Weyenberg W; Apers S; Cos P; Maes L; Ludwig A
Int J Pharm; 2011 Nov; 420(1):122-32. PubMed ID: 21864661
[TBL] [Abstract][Full Text] [Related]
14. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
15. Functionalized
Kang EJ; Baek YM; Hahm E; Lee SH; Pham XH; Noh MS; Kim DE; Jun BH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646562
[TBL] [Abstract][Full Text] [Related]
16. Cyclodextrin-based star polymers as a versatile platform for nanochemotherapeutics: Enhanced entrapment and uptake of idarubicin.
Nafee N; Hirosue M; Loretz B; Wenz G; Lehr CM
Colloids Surf B Biointerfaces; 2015 May; 129():30-8. PubMed ID: 25819363
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of host-guest system to enhance the tamoxifen efficiency.
Heidari Majd M; Akbarzadeh A; Sargazi A
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):441-447. PubMed ID: 27012732
[TBL] [Abstract][Full Text] [Related]
18. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery.
Zhang P; Liu X; Hu W; Bai Y; Zhang L
Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746
[TBL] [Abstract][Full Text] [Related]
20. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
